\-\ Texto\\:\\ \ \(0\)\
\-\ routine\\ labs\\ showed\\ anemia\ \(0\)\
\-\ air\\-contrast\\ be\\:\\ concentric\\ narrowing\\ \\‚\\Ä\\úapple\\ core\\‚\\Ä\\ù\\ lesion\\ of\\ the\\ proximal\\ descending\\ colon\\.\\ \\ \ \(0\)\
\-\ ct\\:\\ corresponds\\ to\\ be\\ findings\\ of\\ a\\ concentrically\\ narrowed\\ lesion\\ of\\ the\\ colon\\ without\\ invasion\\ of\\ the\\ abdominal\\ wall\\ or\\ distant\\ metastases\\.\ \(0\)\
\-\ colon\\ adenocarcinoma\ \(0\)\
\-\ primary\\ colon\\ cancer\ \(1\)\
\-\ metastatic\\ lesion\ \(30\)\
\-\ lymphoma\ \(373\)\
\-\ leiomyoma\ \(85\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ post\\-inflammatory\\ stricture\ \(0\)\
\-\ 34\\ y\\.o\\.\\ woman\\ for\\ screening\\ colonoscopy\\.\\ \\ the\\ gi\\ attending\\ was\\ unable\\ to\\ pass\\ the\\ endoscope\\ beyond\\ the\\ descending\\ colon\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ colon\\:\\ 0\\.5064886629855279\ \(0\)\
\-\ descending\\:\\ 0\\.24032299554543501\ \(0\)\
\-\ concentrically\\:\\ 0\\.21275760335093358\ \(0\)\
\-\ endoscope\\:\\ 0\\.1913876499076233\ \(0\)\
\-\ lesion\\:\\ 0\\.19134492058245586\ \(0\)\
\-\ attending\\:\\ 0\\.1835403632534685\ \(0\)\
\-\ apple\\:\\ 0\\.16737461753253263\ \(0\)\
\-\ the\\:\\ 0\\.15927606749130732\ \(0\)\
\-\ concentric\\:\\ 0\\.15579659673735252\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.15039046358749814\ \(0\)\
\-\ corresponds\\:\\ 0\\.1495998034228106\ \(0\)\
\-\ narrowed\\:\\ 0\\.1428904127448157\ \(0\)\
\-\ distant\\:\\ 0\\.1391292781113036\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.13863826542424912\ \(0\)\
\-\ beyond\\:\\ 0\\.13863826542424912\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.13815737743506754\ \(0\)\
\-\ pass\\:\\ 0\\.13722436337256558\ \(0\)\
\-\ core\\:\\ 0\\.13343405770187472\ \(0\)\
\-\ stricture\\:\\ 0\\.12886021919581106\ \(0\)\
\-\ anemia\\:\\ 0\\.12223083628473322\ \(0\)\
\-\ invasion\\:\\ 0\\.1186700701941893\ \(0\)\
\-\ 34\\:\\ 0\\.11594604950171226\ \(0\)\
\-\ unable\\:\\ 0\\.1152228212812335\ \(0\)\
\-\ gi\\:\\ 0\\.11175519588576545\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.10873703961420204\ \(0\)\
\-\ screening\\:\\ 0\\.10807254334936718\ \(0\)\
\-\ be\\:\\ 0\\.10793684194382282\ \(0\)\
\-\ metastases\\:\\ 0\\.10755424999341212\ \(0\)\
\-\ of\\:\\ 0\\.10414022118265595\ \(0\)\
\-\ narrowing\\:\\ 0\\.10313186657989543\ \(0\)\
\-\ routine\\:\\ 0\\.10302609659732191\ \(0\)\
\-\ labs\\:\\ 0\\.09217032858133396\ \(0\)\
\-\ showed\\:\\ 0\\.08861308079334125\ \(0\)\
\-\ cancer\\:\\ 0\\.08861308079334125\ \(0\)\
\-\ proximal\\:\\ 0\\.0831149388503252\ \(0\)\
\-\ primary\\:\\ 0\\.08180435580741395\ \(0\)\
\-\ wall\\:\\ 0\\.08092888739951419\ \(0\)\
\-\ lymphoma\\:\\ 0\\.07923269402989547\ \(0\)\
\-\ metastatic\\:\\ 0\\.07296498929649912\ \(0\)\
\-\ abdominal\\:\\ 0\\.07276231180956147\ \(0\)\
\-\ without\\:\\ 0\\.07017283303138168\ \(0\)\
\-\ woman\\:\\ 0\\.06928691160671394\ \(0\)\
\-\ to\\:\\ 0\\.06651875213331385\ \(0\)\
\-\ findings\\:\\ 0\\.065659860421601\ \(0\)\
\-\ ct\\:\\ 0\\.05064902489693682\ \(0\)\
\-\ was\\:\\ 0\\.046365251671143054\ \(0\)\
\-\ or\\:\\ 0\\.04628174246290004\ \(0\)\
\-\ for\\:\\ 0\\.04032296334864921\ \(0\)\
